drugset / Trial / NCT04182633
MTT for Children With ASD Who Have Gastrointestinal Disorders
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The investigators propose to investigate Microbiota Transfer Therapy (MTT) for treating children with Autism Spectrum Disorder (ASD) and gastrointestinal problems (primarily constipation and/or diarrhea). MTT involves a combination of 10 days of oral vancomycin (an antibiotic to kill pathogenic bacteria), followed by a bowel cleanse, followed by 12 weeks of Fecal Microbiota (FM).
Timeline
- Start
- 2019-11-15
- Primary completion
- 2025-02-28
- Completion
- 2025-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vancomycin | Other / unclassified | — | Oral |
| Subject | intestinal microbiota | Unknown | — | Oral |
| Background | polyethylene glycol | Other / unclassified | — | — |